Related Experiment Videos
Erythema elevatum diutinum--a case successfully treated with colchicine
Clinical and Experimental Dermatology
|November 1, 1989
Summary
Erythema elevatum diutinum (EED) resistant to dapsone treatment was effectively managed with colchicine. This case highlights colchicine as a viable alternative therapy for refractory EED.
Area of Science:
- Dermatology
- Rheumatology
- Internal Medicine
Background:
- Erythema elevatum diutinum (EED) is a rare, chronic vasculitis presenting with persistent skin lesions.
- Standard treatments for EED often include dapsone, but therapeutic resistance can occur.
Observation:
- This report details a case of EED in a patient who did not respond to dapsone therapy.
- The patient's EED lesions were persistent and unresponsive to conventional dapsone treatment.
Findings:
- Successful resolution of EED lesions was achieved using colchicine.
- Colchicine demonstrated significant efficacy in managing this dapsone-unresponsive case of EED.
Implications:
- Colchicine represents a promising therapeutic option for patients with erythema elevatum diutinum refractory to dapsone.
- This finding expands treatment strategies for rare vasculitic conditions, improving patient outcomes.